Trial intelligence / Profile preview

Prevention of Intrauterine Growth Retardation: Malaria Component

NCT00680732Phase 4Completed

Sponsor
Institute of Tropical Medicine Antwerp
Start
Jun 2003
Primary completion
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of chloroquine, sulfadoxine + pyrimethamine in malaria, sponsored by Institute of Tropical Medicine Antwerp. Started Jun 2003; status: completed.

02

Drugs

chloroquinesulfadoxine + pyrimethamine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT00680732.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00680732.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call